Your browser doesn't support javascript.
loading
A cellular and molecular biology-based update for ivermectin against COVID-19: is it effective or non-effective?
Nabi-Afjadi, Mohsen; Mohebi, Fatemeh; Zalpoor, Hamidreza; Aziziyan, Fatemeh; Akbari, Abdullatif; Moradi-Sardareh, Hemen; Bahreini, Elham; Moeini, Amir Mansour; Effatpanah, Hossein.
Afiliação
  • Nabi-Afjadi M; Department of Biochemistry, Faculty of Biological Sciences, University of Tarbiat Modares, Tehran, Iran. Mohsennabi66@gmail.com.
  • Mohebi F; Molecular Medicine Research Center, Hormozghan Health Institute, Hormozghan University of Medical Sciences, Bandar Abbas, Iran.
  • Zalpoor H; Shiraz Neuroscience Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Aziziyan F; Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran.
  • Akbari A; Department of Biochemistry, Faculty of Biological Sciences, University of Tarbiat Modares, Tehran, Iran.
  • Moradi-Sardareh H; Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran.
  • Bahreini E; Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran.
  • Moeini AM; Asadabad School of Medical Science, Hamedan, Asadabad, Iran. hemen.moradi@yahoo.com.
  • Effatpanah H; Department of Biochemistry, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran. elhambahreini@yahoo.com.
Inflammopharmacology ; 31(1): 21-35, 2023 Feb.
Article em En | MEDLINE | ID: mdl-36609716

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Limite: Humans Idioma: En Revista: Inflammopharmacology Assunto da revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Irã

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Limite: Humans Idioma: En Revista: Inflammopharmacology Assunto da revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Irã